Retatrutide and Type 1 Diabetes: Evidence, Risks, and UK Guidance Retatrutide and type 1 diabetes is an emerging area of scientific interest, though the evidence base remains at a very early stage
Sex hormones, intestinal inflammation, and the gut microbiome: major influencers of the sexual dimorphisms in obesity
Furthermore, chronic treatment with the GLP-1 mimetic liraglutide induces similar improvements on glucose tolerance despite the loss of PNS or CNS-GLP-1R expression, indicating that non-neuronal GLP-1R signaling is sufficient for the long-term improvements in glucose homeostasis induced by liraglutide in mice (Sisley et al., 2014)
More research into their safety and tolerability in IBD patients is necessary
Are these early indicators that therapeutic ranges are applicable for all nutrients
Future studies using additional cell types (e.g., primary cells and differentiated induced pluripotent stem cells), other stress conditions, and in vivo models should provide a more comprehensive understanding of ASPLs role in the dynamic regulation of SGs and other RNP granules
